KESTRA MEDICAL TECHNOLOGIES, LTD.·4

Jun 4, 6:39 PM ET

Ford Alfred J Jr 4

4 · KESTRA MEDICAL TECHNOLOGIES, LTD. · Filed Jun 4, 2026

Research Summary

AI-generated summary of this filing

Updated

Kestra Medical (KMTS) CCO Alfred Ford Receives 25,227 RSUs

What Happened Alfred J. Ford Jr., Chief Commercial Officer of Kestra Medical Technologies, Ltd. (KMTS), was granted 25,227 restricted stock units (RSUs) on June 3, 2026. The units were reported as acquired at $0.00 (no immediate cash value); settlement will convert each vested RSU into one common share upon vesting.

Key Details

  • Transaction type: Award/Grant (RSUs) — 25,227 units acquired at $0.00 on 2026-06-03.
  • Filing date: Form 4 filed 2026-06-04 (reporting period 2026-06-03).
  • Shares owned after transaction: Not specified in the provided filing details.
  • Footnote: RSUs vest over three years, with 1/3 vesting on each anniversary of June 3, 2026, subject to continued service.
  • No sale or purchase (cash) occurred; this is a time-based equity award, not a market transaction.

Context RSU awards are a common form of long-term compensation for executives and align retention incentives; they do not represent immediately tradeable shares until they vest. This grant alone is a compensation event and should not be read as a direct buy/sell signal.

Insider Transaction Report

Form 4
Period: 2026-06-03
Ford Alfred J Jr
Chief Commercial Officer
Transactions
  • Award

    Common Shares

    [F1]
    2026-06-03+25,22774,639 total
Footnotes (1)
  • [F1]Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest over three years, with 1/3 vesting on each anniversary of June 3, 2026.
Signature
/s/ Traci S. Umber as attorney-in-fact for Alfred J. Ford Jr.|2026-06-04

Documents

1 file
  • 4
    ownership.xmlPrimary

    4